We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VTGN market cap is 79.29M. The company's latest EPS is USD -1.0173 and P/E is -2.61.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 412k | 197k | 84k | 183k | 234k |
| Operating Income | -7.88M | -11.36M | -12.13M | -14.23M | -15.12M |
| Net Income | -6.35M | -9.52M | -10.73M | -12.96M | -14.09M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 1.09M | 1.11M | -227k | 1.06M |
| Operating Income | -20.8M | -17.93M | -47.78M | -59.27M | -33.02M |
| Net Income | -22.04M | -42.32M | -48.71M | -59.25M | -29.36M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 131.07M | 123.65M | 113.55M | 102.5M | 92.31M |
| Total Liabilities | 7.78M | 9.37M | 8.75M | 9.52M | 11.19M |
| Total Equity | 123.29M | 114.29M | 104.8M | 92.97M | 81.12M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.77M | 108.28M | 74.64M | 21.09M | 123.65M |
| Total Liabilities | 11.5M | 16.3M | 9.93M | 9.01M | 9.37M |
| Total Equity | -5.73M | 91.98M | 64.72M | 12.08M | 114.29M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.62M | -25.81M | -10.87M | -21.76M | -32.04M |
| Investing | -32k | -61k | -5.47M | -13.25M | -13.68M |
| Financing | 128.57M | 128.4M | 88k | 88k | 1.26M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.76M | -12.07M | -45.26M | -49.72M | -25.81M |
| Investing | N/A | -275k | -200k | -740k | -61k |
| Financing | 4.01M | 114.1M | 10.48M | -1.04M | 128.4M |
| Market Cap | 79.29M |
| Price to Earnings Ratio | -2.61 |
| Price to Sales Ratio | 72.09 |
| Price to Cash Ratio | 0.64 |
| Price to Book Ratio | 0.67 |
| Dividend Yield | - |
| Shares Outstanding | 28.86M |
| Average Volume (1 week) | 158.68k |
| Average Volume (1 Month) | 164.48k |
| 52 Week Change | -34.43% |
| 52 Week High | 5.74 |
| 52 Week Low | 2.22 |
| Spread (Intraday) | 0.03 (1.09%) |
| Company Name | Vistagen Therapeutics Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.vistagen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
